Willowbrooke at Tanner

Willowbrooke at Tanner

Services:
Treatment Approaches
• Telemedicine/telehealth therapy
• Anger management
• Relapse prevention
• Brief intervention
• Trauma-related counseling
• Cognitive behavioral therapy
• Matrix Model
• Motivational interviewing
• Substance use disorder counseling

Assessment/Pre-treatment

• Screening for tobacco use
• Comprehensive mental health assessment
• Comprehensive substance use assessment
• Outreach to persons in the community
• Screening for mental disorders
• Screening for substance use
• Interim services for clients

Special Programs/Groups Offered

• Clients with co-occurring mental and substance use disorders
• Adolescents

Facility Vaping Policy

• Vaping permitted in designated area

Education and Counseling Services

• Group counseling
• Hepatitis education, counseling, or support
• HIV or AIDS education, counseling, or support
• Health education services other than HIV/AIDS or hepatitis
• Individual counseling
• Family counseling
• Substance use disorder education
• Smoking/vaping/tobacco cessation counseling

Gender Accepted

• Male
• Female

Facility Operation (e.g., Private, Public)

• Private non-profit organization

Type of Alcohol Use Disorder Treatment

• Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere
• This facility administers/prescribes medication for alcohol use disorder

Facility Smoking Policy

• Smoking permitted in designated area

Payment/Insurance/Funding Accepted

• Private health insurance
• Cash or self-payment
• Medicaid
• Medicare

Age Groups Accepted

• Adults
• Young Adults

Testing

• Breathalyzer or blood alcohol testing
• Drug or alcohol urine screening

External Source of Medications Used for Alcohol Use Disorder Treatment

• Other contracted prescribing entity
• In-network prescribing entity
• No formal relationship with prescribing entity

Pharmacotherapies

• Non-nicotine smoking/tobacco cessation
• Acamprosate (Campral�)
• Naltrexone (oral)
• Nicotine replacement
• Naltrexone (extended-release, injectable)
• Lofexidine
• Buprenorphine with naloxone
• Buprenorphine (extended-release, injectable)
• Medication for mental disorders
• Buprenorphine without naloxone
• Clonidine

Type of Opioid Treatment

• Prescribes naltrexone
• Buprenorphine maintenance
• Accepts clients using MAT but prescribed elsewhere
• Relapse prevention with naltrexone
• Prescribes buprenorphine
• Maintenance service with medically supervised withdrawal after stabilization

License/Certification/Accreditation

• The Joint Commission
• Hospital licensing authority

Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)

• Regular outpatient treatment
• Intensive outpatient treatment
• Outpatient day treatment or partial hospitalization
• Outpatient methadone/buprenorphine or naltrexone treatment
• Outpatient

Hospitals

• General Hospital (including VA hospital)

Recovery Support Services

• Mentoring/peer support

External Opioid Medications Source

• No formal relationship with prescribing entity

Transitional Services

• Discharge Planning
• Outcome follow-up after discharge
• Naloxone and overdose education
• Aftercare/continuing care

Language Services

• Sign language services for the deaf and hard of hearing

Type of Care

• Substance use treatment
• Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children

Other Services

• Treatment for other addiction disorder

Ancillary Services

• Domestic violence services, including family or partner
• Suicide prevention services
• Case management service
• Transportation assistance
• Mental health services
• Social skills development

Opioid Medications used in Treatment

• Buprenorphine used in Treatment
• Naltrexone used in Treatment